| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005771899 |
| 005 |
20260327174531.0 |
| 006 |
m o d |
| 007 |
cr cn |||||||| |
| 008 |
230523t20232023enka ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d UKAHL
|d UKMGB
|d OCLCF
|d VTM
|d OCLCO
|d OCLCL
|d YDX
|d OCLCO
|d SXB
|d OCLCQ
|d OCLCO
|d OCLCL
|d N$T
|d EBLCP
|d UKKRT
|d PAU
|
| 015 |
|
|
|a GBC351351
|2 bnb
|
| 016 |
7 |
|
|a 020985451
|2 Uk
|
| 019 |
|
|
|a 1378357675
|a 1378935209
|a 1379193420
|a 1426263412
|a 1428756476
|a 1480904285
|a 1481015298
|
| 020 |
|
|
|a 9780323917155
|q electronic book
|
| 020 |
|
|
|a 0323917151
|q electronic book
|
| 020 |
|
|
|z 9780323913676
|q print
|
| 020 |
|
|
|z 0323913679
|q print
|
| 024 |
7 |
|
|a 10.1016/C2021-0-01040-3
|2 doi
|
| 035 |
|
|
|a (OCoLC)1379807579
|z (OCoLC)1378357675
|z (OCoLC)1378935209
|z (OCoLC)1379193420
|z (OCoLC)1426263412
|z (OCoLC)1428756476
|z (OCoLC)1480904285
|z (OCoLC)1481015298
|
| 037 |
|
|
|a 9780323917155
|b Ingram Content Group
|
| 050 |
|
4 |
|a RC271.G45
|b E65 2023
|
| 060 |
|
4 |
|a QZ 202
|
| 082 |
0 |
4 |
|a 616.994/042
|2 23/eng/20230523
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a Epigenetic cancer therapy /
|c edited by Steven G. Gray.
|
| 250 |
|
|
|a Second edition.
|
| 264 |
|
1 |
|a London ;
|a San Diego, CA :
|b Academic Press is an imprint of Elsevier,
|c [2023]
|
| 264 |
|
4 |
|c ©2023
|
| 300 |
|
|
|a 1 online resource :
|b illustrations.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Translational epigenetics series
|
| 520 |
|
|
|a "Epigenetic Cancer Therapy, Second Edition provides a comprehensive discussion of healthy and aberrant epigenetic biology, along with new discoveries to improve our understanding of cancer epigenetics and therapeutics. The book encompasses large-scale intergovernmental initiatives, as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Since the publication of the first edition of this book, the field of epigenetics has undergone significant change. New epigenetic therapies have been designed and approved for clinical use"--
|c From ScienceDirect.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Methylation and hydroxymethylation in cancer / Fazila Asmar, Linn Gillberg and Kirsten Grønbæk -- Writers, erasers, and readers of DNA and histone methylation marks / Jiameng Dan and Taiping Chen -- Oncohistones / Kristen Orumaa and Steven G. Gray -- microRNA, epi-microRNA, and cancer / Michaela B. Kirschner, Harriet R. Walker and Hannah L. Moody -- Long noncoding RNA in human cancers : to be or not to be, that is the question / Sonia Cinque, Marianna Aprile, ... Eleonora Leucci -- The emerging roles of epitranscriptomic marks in cancer / Mirolyuba Ilieva, Sakari Kauppinen and Shizuka Uchida -- Epigenomic profiling at genome scale : from assays and analysis to clinical insights / Sarah Ennis, Barry Digby and Pilib Ó Broin -- Environmental pollution, epigenetics, and cancer / Catherine E. Keenan, Robbie Kelleher and Steven G. Gray -- Synthetic biology and cell engineering-deriving new insights into cancer epigenetics / Kierra A. Franklin and Karmella A. Haynes -- Epigenetic targeted therapies in hematological malignancies / Deirdra Venney, Graeme Greenfield, ... Ken I. Mills -- Epigenetic therapy in lung cancer / Michael Conroy, Áine O'Connor, ... Catríona M. Dowling -- Breast cancer epigenetics / Evanthia T. Roussos Torres and Roisin M. Connolly -- Therapeutic applications of the prostate cancer epigenome / Joanne M. Cosgrave and Antoinette S. Perry -- Neuroblastoma / Ellen King, Nadiya Bayeva, ... Olga Piskareva -- Epigenetic therapies-update on lysine methyltransferase/PRC complex inhibitors / Sunkyu Kim, Natalie Barkey, ... Dashyant Dhanak -- Inhibitors of Jumonji-C domain-containing histone demethylases / Veronica Sian, José A. Souto, ... Lucia Altucci -- Emerging epigenetic therapies-lysine acetyltransferase inhibitors / Stephanie Kaypee, Siddharth Singh, ... Tapas K. Kundu -- Epigenetic therapies : histone deacetylases / Christophe Blanquart -- Epigenetic intratumoral heterogeneity / Shijie C. Zheng -- Challenges for single-cell epigenetic analysis / Eyal Metzl-Raz, Samuel H. Kim, ... William J. Greenleaf -- Epigenetics of cisplatin resistance / Anne-Marie Baird and Steven G. Gray -- Emerging epigenetic therapies : protein arginine methyltransferase inhibitors / Hannah Pook and Siim Pauklin -- Personalized epigenetic therapy-chemosensitivity testing / Leandro Cerchietti -- Epigenetic profiling in cancer : triage, prognosis, and precision oncology / Cristiana Banila -- Epigenetic priming-fact or falacy? / Maria Revuelta and Leandro Cerchietti -- CRISPR, epigenetics, and cancer / Andrea Martella.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed August 12, 2025).
|
| 650 |
|
0 |
|a Cancer
|x Gene therapy.
|
| 650 |
|
0 |
|a Cancer
|x Genetic aspects.
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
0 |
|a Epigenesis.
|
| 650 |
|
0 |
|a Gene therapy.
|
| 650 |
|
2 |
|a Neoplasms
|x genetics
|
| 650 |
|
2 |
|a Epigenesis, Genetic
|
| 650 |
|
2 |
|a Neoplasms
|x therapy
|
| 650 |
|
2 |
|a Genetic Therapy
|
| 650 |
|
6 |
|a Cancer
|x Aspect génétique.
|
| 650 |
|
6 |
|a Cancer
|x Traitement.
|
| 650 |
|
6 |
|a Épigénèse.
|
| 650 |
|
6 |
|a Thérapie génique.
|
| 650 |
|
6 |
|a Cancer
|x Thérapie génique.
|
| 650 |
|
7 |
|a Cancer
|x Genetic aspects
|2 fast
|
| 650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|
| 650 |
|
7 |
|a Epigenesis
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Gray, Steven G.
|c (Thoracic oncology researcher),
|e editor.
|1 https://id.oclc.org/worldcat/entity/E39PCjwxdYbBb7yj4kWCGJVrxC
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 758 |
|
|
|i has work:
|a Epigenetic cancer therapy (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGCBdgy8vkpTb8whYhDj83
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|t Epigenetic cancer therapy.
|b Second edition
|d London ; San Diego, CA : Academic Press is an imprint of Elsevier, [2023]
|z 9780323913676
|w (OCoLC)1372469054
|
| 830 |
|
0 |
|a Translational epigenetics series.
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/book/9780323913676
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i aac7633e-de6b-4914-8f87-8d4d3ce2d96b
|s 588fb78b-3d0c-4cf5-9685-471daee1eed7
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e RC271.G45 E65 2023
|h Library of Congress classification
|
| 998 |
f |
f |
|a RC271.G45 E65 2023
|t 0
|l Available Online
|